TABLE 4.
Variable | Na | Ratio (95% CI) | z Test, P | TOST | |
---|---|---|---|---|---|
z1 P | z2 P | ||||
PPVb | .01 | .86 | <.001 | ||
M-CHAT | 98 | 0.40 (0.30–0.50) | |||
PCP M-CHAT/F | 98 | 0.58 (0.48–0.67) | |||
PPVc | .49 | .24 | .02 | ||
PCP M-CHAT/F | 98 | 0.58 (0.48–0.67) | |||
AC M-CHAT/F | 97 | 0.53 (0.43–0.63) | |||
Sensitivityc | .37 | .30 | .01 | ||
PCP M-CHAT/F | 98 | 0.59 (0.49–0.69) | |||
AC M-CHAT/F | 97 | 0.53 (0.43–0.63) | |||
Specificityc | .80 | .10 | .04 | ||
PCP M-CHAT/F | 98 | 0.71 (0.62–0.80) | |||
AC M-CHAT/F | 97 | 0.69 (0.60–0.79) | |||
Accuracyc | .62 | .17 | .02 | ||
PCP M-CHAT/F | 98 | 0.67 (0.57–0.76) | |||
AC M-CHAT/F | 97 | 0.63 (0.53–0.73) |
Comparisons were made with 2-tailed z test and TOST, Δ = 0.1 unit of proportion. Only patients with a positive screen on the M-CHAT are included in this sample. CI, confidence interval.
One patient did not have a complete AC M-CHAT/F (Fig 1).
Relevant difference.
Equivalence.